Our analysis not only confirms previous findings indicating low adiponectin levels in severe COVID-19, but also suggests that a combination of low adiponectin and high CRP and procalcitonin levels may represent a novel biomarker signature for severe COVID-19. The gene discussed is ADIPOQ; the disease is COVID-19.